Cancer Immunotherapy by Diagnosis

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
Changing the Outlook of Cancer Treatment

The time for advancements in cancer treatment technology is now, with immunotherapy representing one of the most promising cancer opponents of our time. Below, you'll find a list of the specific cancer types for which immunotherapy has already garnered impressive results, with more cancer diagnoses added regularly.

Bladder Cancer
Bladder cancer was the first indication for which an immunotherapy was granted approval by the Food and Drug Administration (FDA) in 1990.
Brain Cancer
Malignant brain tumors are relatively rare but very serious form of cancer. Immunotherapy is showing significant promise where other approaches have failed.
Breast Cancer
Each year, breast cancer accounts for 12 percent of all cancers diagnosed globally.
Cervical Cancer
By far, the most significant cause of cervical cancer, as well as other ano-genital cancers, is infection with a virus—the human papillomavirus (HPV).
Childhood Cancer
Cancer affects an estimated 300,000 young people every year. Immunotherapy has the potential to improve both their survival and quality of life.
Colorectal Cancer
Colorectal cancer is the third most common type of cancer among both men and women in the United States, and is the second most deadly.
Esophageal Cancer
There are two main types of esophageal cancer: squamous cell carcinoma and adenocarcinoma.
Head and Neck Cancer
While many different types of cancer can occur in the head and neck, squamous cell carcinoma in the most common cancer of the head and neck.
Kidney Cancer
About 9 out of every 10 kidney cancers are renal cell carcinomas—cancers that form in the lining of the tubules inside the kidney.
Leukemia is a cancer of the bone marrow and blood and is classified by cell type and rate of growth: acute lymphocytic, chronic lymphocytic, acute myeloid, and chronic myeloid.
Liver Cancer
When diagnosed early, liver cancer can be treated successfully with surgery, but liver donors are rare and few treatment options exist for patients with advanced disease.
Lung Cancer
In the U.S., lung cancer is by far the leading cause of cancer-related death among both men and women; causing more deaths annually than breast, prostate, and colon cancer combined.
Lymphoma is the name for a group of blood cancers that develop in certain immune cells. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL).
Melanoma accounts for the majority of skin cancer-related deaths. Over the past few years, immunotherapy has dramatically changed the landscape of melanoma treatment.
Multiple Myeloma
Myeloma—also referred to as multiple myeloma or plasma cell myeloma—is a cancer that originates in plasma cells, a type of white blood cell that make antibodies.
Ovarian Cancer
Ovarian cancer often progresses before symptoms arise. Nine out of 10 ovarian cancers are epithelial, deriving from the outer layer of the ovary.
Pancreatic Cancer
Pancreatic cancer is the most lethal cancer, and new therapies are urgently needed to impact pancreatic cancer treatment and to extend and save pancreatic cancer patients’ lives.
Prostate Cancer
Prostate cancer is the second most common cancer in men worldwide, and the eighth leading cause of cancer-related death.
Sarcoma is a rare cancer in adults (1% of all adult cancers), but rather prevalent in children (about 15% of all childhood cancers).
Stomach Cancer
Stomach cancer is the fifth most common diagnosis in cancer, and it is the third most deadly, with nearly 725,000 deaths.

*Immunotherapy results may vary from patient to patient.